A machine learning classifier using 33 host immune response mRNAs accurately distinguishes viral and non-viral acute respiratory illnesses in nasal swab samples.

Journal: Genome medicine
PMID:

Abstract

BACKGROUND: Viral acute respiratory illnesses (viral ARIs) contribute significantly to human morbidity and mortality worldwide, but their successful treatment requires timely diagnosis of viral etiology, which is complicated by overlap in clinical presentation with the non-viral ARIs. Multiple pandemics in the twenty-first century to date have further highlighted the unmet need for effective monitoring of clinically relevant emerging viruses. Recent studies have identified conserved host response to viral infections in the blood.

Authors

  • Rushika Pandya
    Inflammatix Inc., CA, 94085, Sunnyvale, USA.
  • Yudong D He
    Inflammatix Inc., CA, 94085, Sunnyvale, USA.
  • Timothy E Sweeney
    Biomedical Informatics Training Program, Stanford University, Stanford CA 94305-5479, USA.
  • Yehudit Hasin-Brumshtein
    Inflammatix Inc., CA, 94085, Sunnyvale, USA.
  • Purvesh Khatri
    Department of Radiation Oncology, Stanford University School of Medicine , Stanford, California 94305, United States.